olivLaw · US equity research
Flotek Industries, Inc. FTK
Miscellaneous Chemical Products · SIC 2890 · Vertical: Miscellaneous Chemical Products (SIC 2890)
Flotek Industries is a chemistry and data analytics company serving mainly the energy industry, with Chemistry Technologies and Data Analytics segments. Its second quarter of 2026 showed strong growth, and the Data Analytics segment became the largest contributor to gross profit, which draws attention to diversification beyond oil and gas.
The AI analysis may be outdated: new filings came after its sources (see the «AI analysis» section).
At the close of 05 Nov 2026, Flotek Industries, Inc. (FTK) stock was 22.16 USD (−10.36% on the day), with market capitalisation 802.6 m USD, P/E 22.4 on diluted EPS of 0.99 USD over the last 12 months, beta 1.90, 52-week range 13.47–38.82 USD. Latest reported quarter (Q2 2026): revenue of 99.4 m USD (+70.3% YoY), net income of 10.0 m USD (+463.0% YoY), diluted EPS 0.26 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 37.1
- weak (30–45)
- Bollinger (20, 2)
- 22.51 – 27.15
- below the lower band · %B -0.08 · band width 18.7%
- SMA 50 / 200
- 26.50 / 22.18
- mixed trend
- MACD (12, 26, 9)
- -0.90 / -0.80
- MACD below signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | −26.1% | −1.1% | −25.0 pp | — |
| 3 months | −39.2% | −0.5% | −38.7 pp | — |
| 6 months | +36.8% | +4.4% | +32.4 pp | — |
| Year to date | +28.6% | +12.3% | +16.3 pp | — |
| 1 year | +31.4% | +13.5% | +17.9 pp | −10.0% |
| 3 years | +404.8% | +76.4% | +328.4 pp | −6.0% |
| 5 years | +221.2% | +63.7% | +157.5 pp | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q2 2026 · 30 Jun 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 49.7 m | 50.8 m | 55.4 m | 58.4 m | 56.0 m | 67.5 m | 70.1 m | 99.4 m |
| Cost of revenue | 40.6 m | 38.5 m | 42.9 m | 43.9 m | 38.2 m | 52.3 m | 54.5 m | 75.6 m |
| Gross profit | 9.1 m | 12.3 m | 12.4 m | 14.4 m | 17.8 m | 15.2 m | 15.5 m | 23.8 m |
| Research & development | 462.0 k | 365.0 k | 355.0 k | 455.0 k | 549.0 k | 463.0 k | 396.0 k | 497.0 k |
| SG&A | 5.7 m | 6.6 m | 6.3 m | 6.8 m | 7.4 m | 7.6 m | 6.9 m | 7.7 m |
| Operating income | 2.7 m | 5.1 m | 5.6 m | 2.6 m | 9.1 m | 6.0 m | 7.6 m | 14.9 m |
| Interest expense | 256.0 k | 253.0 k | 229.0 k | 983.0 k | 1.4 m | 1.4 m | 1.3 m | 1.4 m |
| Pre-tax income | 2.6 m | 4.8 m | 5.4 m | 1.8 m | 7.7 m | 4.7 m | 6.3 m | 13.5 m |
| Income tax | 37.0 k | 356.0 k | 64.0 k | 17.0 k | -12.6 m | 1.7 m | 1.6 m | 3.6 m |
| Net income | 2.5 m | 4.4 m | 5.4 m | 1.8 m | 20.4 m | 3.0 m | 4.7 m | 10.0 m |
| Diluted EPS | 0.08 | 0.14 ≈ | 0.17 | 0.05 | 0.53 | 0.08 ≈ | 0.12 | 0.26 |
| Operating cash flow | 5.1 m ≈ | -2.6 m | 7.3 m | -4.5 m ≈ | -1.9 m ≈ | 6.2 m | 21.0 k | -6.6 m ≈ |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 50 percentile of its own 12-quarter history (min 16.4, median 23.0, max 72.5; quarters with earnings only).
Fiscal years
| Fiscal year | 2018 | 2019 | ⚠ 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 177.8 m | 119.4 m | 53.1 m | 43.3 m | 136.1 m | 188.1 m | 187.0 m | 237.3 m |
| Revenue YoY | −26.9% | −32.9% | — | −18.6% | +214.5% | +38.2% | −0.5% | +26.9% |
| Net income | -70.3 m | -33.9 m | -136.5 m | -30.5 m | -42.3 m | 24.7 m | 10.5 m | 30.5 m |
| Net income YoY | unavailable | unavailable | — | unavailable | unavailable | unavailable | −57.5% | +190.8% |
| Diluted EPS | -1.21 | -0.55 | -2.00 | -0.42 | -3.41 | -0.10 | 0.34 | 0.84 |
| Diluted EPS YoY | unavailable | unavailable | — | unavailable | unavailable | unavailable | unavailable | +147.1% |
| net % | -39.6% | -28.4% | -256.8% | -70.6% | -31.1% | 13.1% | 5.6% | 12.9% |
| Free cash flow | unavailable | unavailable | -49.3 m | -25.9 m | -45.1 m | unavailable | unavailable | unavailable |
The series breaks before 2020: earlier years come from the original reports of the issuer of that time, later years from a subsequent filing that restated the perimeter (a separation, discontinued operations). The year-on-year change across the break is not shown.
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 5.7 m USD
- Financial debt
- 40.0 m USD
- Net debt
- 34.3 m USD
- Equity
- 113.1 m USD
- Total assets
- 220.0 m USD
- Debt / equity
- 0.35x
- Current ratio
- 1.80x
- ROE
- 26.9%
- ROA
- 15.6%
- FCF margin
- unavailable
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | 53.1 m | 43.3 m | 136.1 m | 188.1 m | 187.0 m | 237.3 m | SEC (XBRL)· 16 Mar 2026verified |
| Cost of revenue | 81.8 m | 40.0 m | 142.8 m | 163.8 m | 147.6 m | 177.4 m | SEC (XBRL)· 16 Mar 2026verified |
| Gross profit | -28.7 m | 3.3 m | -6.7 m | 24.3 m | 39.4 m | 59.8 m | SEC (XBRL)· 16 Mar 2026verified |
| Research & development | 7.2 m | 5.5 m | 4.4 m | 2.5 m | 1.7 m | 1.8 m | SEC (XBRL)· 16 Mar 2026verified |
| SG&A | 22.8 m | 20.2 m | 27.1 m | 27.8 m | 24.7 m | 28.0 m | SEC (XBRL)· 16 Mar 2026verified |
| Operating income | -143.6 m | -31.5 m | -35.4 m | 23.2 m | 12.2 m | 23.2 m | SEC (XBRL)· 16 Mar 2026verified |
| Depreciation & amortisation | 3.4 m | 1.0 m | — | — | — | — | SEC (XBRL)· 31 Mar 2022verified |
| EBITDA | -140.2 m ≈ | -30.4 m ≈ | — | — | — | — | SEC (XBRL)· 31 Mar 2022derived |
| Interest expense | 60.0 k | 78.0 k | 7.1 m | 2.9 m | 1.1 m | 3.9 m | SEC (XBRL)· 16 Mar 2026verified |
| Pre-tax income | -142.6 m | -30.6 m | -42.3 m | 24.9 m | 11.1 m | 19.7 m | SEC (XBRL)· 16 Mar 2026verified |
| Income tax | -6.2 m | -40.0 k | -22.0 k | 149.0 k | 649.0 k | -10.9 m | SEC (XBRL)· 16 Mar 2026verified |
| Net income | -136.5 m | -30.5 m | -42.3 m | 24.7 m | 10.5 m | 30.5 m | SEC (XBRL)· 16 Mar 2026verified |
| Diluted EPS | -2.00 | -0.42 | -3.41 | -0.10 | 0.34 | 0.84 | SEC (XBRL)· 16 Mar 2026verified |
| Weighted average diluted shares | 68.3 m | 73.4 m | 12.4 m | 28.4 m | 30.9 m | 36.2 m | SEC (XBRL)· 16 Mar 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating income + Depreciation & amortisation.
Balance sheet · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 38.7 m | 11.5 m | 12.3 m | 5.9 m | 4.4 m | 5.7 m | SEC (XBRL)· 16 Mar 2026verified |
| Receivables | 11.8 m | 12.0 m | 19.1 m | — | — | — | SEC (XBRL)· 23 Mar 2023verified |
| Inventories | 11.8 m | 9.5 m | 15.7 m | 12.8 m | 13.3 m | 10.6 m | SEC (XBRL)· 16 Mar 2026verified |
| Current assets | 66.5 m | 42.6 m | 80.1 m | 76.4 m | 96.5 m | 110.8 m | SEC (XBRL)· 16 Mar 2026verified |
| Goodwill | 8.1 m | 0 | — | — | — | — | SEC (XBRL)· 31 Mar 2022verified |
| Total assets | 86.2 m | 50.2 m | 164.8 m | 157.5 m | 170.8 m | 220.0 m | SEC (XBRL)· 16 Mar 2026verified |
| Accounts payable | 5.8 m | 7.6 m | 33.4 m | 31.7 m | 38.1 m | 48.3 m | SEC (XBRL)· 16 Mar 2026verified |
| Short-term debt | 4.0 m | 1.4 m | — | — | — | — | SEC (XBRL)· 31 Mar 2022verified |
| Long-term debt | 1.6 m | 3.4 m | 2.7 m | 60.0 k | 0 | 40.0 m | SEC (XBRL)· 16 Mar 2026verified |
| Current liabilities | 28.9 m | 18.8 m | 151.4 m | 47.8 m | 50.4 m | 61.6 m | SEC (XBRL)· 16 Mar 2026verified |
| Total liabilities | 39.0 m | 30.1 m | 162.2 m | 55.6 m | 56.9 m | 107.0 m | SEC (XBRL)· 16 Mar 2026verified |
| Equity | 47.2 m † | 20.2 m † | 2.6 m † | 102.0 m † | 113.9 m † | 113.1 m † | SEC (XBRL)· 16 Mar 2026verified |
† equity attributable to the parent's shareholders: in these years the issuer no longer reports the total including non-controlling interests.
Cash flow · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -47.8 m | -25.8 m | -44.6 m | -11.3 m | 3.4 m | 7.2 m | SEC (XBRL)· 16 Mar 2026verified |
| Capex | 1.4 m | 39.0 k | 421.0 k | — | — | — | SEC (XBRL)· 23 Mar 2023verified |
| Free cash flow | -49.3 m ≈ | -25.9 m ≈ | -45.1 m ≈ | — | — | — | SEC (XBRL)· 23 Mar 2023derived |
| Investing cash flow | -17.7 m | 112.0 k | 5.3 m | -1.0 m | -1.8 m | -2.0 m | SEC (XBRL)· 16 Mar 2026verified |
| Financing cash flow | 3.7 m | -372.0 k | 38.3 m | 5.9 m | -3.1 m | -3.7 m | SEC (XBRL)· 16 Mar 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
Risk
Valuation
olivLaw classification
- score weight coverage: 45.8% of at least 60%
A scoring methodology on indicators and valuation, not investment advice.
Closing price
05 Nov 2026Source: olivLaw, closing series
Market cap: 802.6 m USD
Key indicators
Coverage and freshness
Score by group
46% · Insufficient data
Estimated value range
The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 28.12 – 36.48 USD.
Valuation assumptions are editorial choices, not measured; beta is not measured.
Method ranges (USD per share)
— — Mid · ▏ Price
Valuation methods
- DCF (discounted cash flow)unavailable · the input exists, but its latest figure is far older than the latest reported period: not used
- Peers: EV/EBITDAunavailable · input data missing
- Peers: P/E28.12 – 36.48 (Mid 35.99)3 companies used · median multiple 36.4x · quartiles 28.4x – 36.9xCBT, ESI, WDFC
- Dividend discount (DDM)unavailable · the company pays no dividend: a dividend model needs an explicit initiation assumption
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Insufficient data
Minimum-evidence gate: score weight coverage: 45.8% of at least 60%
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | 23.2% | 83 (vs peers) | 23% |
| Net margin · Quality | 13.0% | 100 (vs peers) | 14% |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | 20.4% | 100 (on a fixed band) | 18% |
| EPS CAGR 3Y · Growth | unavailable | unavailable | — |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | 6.9x | 83 (on a fixed band) | 14% |
| Current ratio · Balance sheet | 1.8x | 82 (on a fixed band) | 9% |
| P/E (TTM) · Valuation | 22.4x | 35 (on a fixed band) | 23% |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | unavailable | unavailable | — |
| Shareholder yield (distributions) · Returns | unavailable | unavailable | — |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet83/100 · 2/3 factors with a value
- Growth· partial100/100 · 1/2 factors with a value
- Quality90/100 · 2/3 factors with a value
- Returns· partialunavailable · 0/2 factors with a value
- Valuation· partial35/100 · 1/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
FLOTEK INDUSTRIES INC/CN (FTK). Latest full fiscal year: 2025; data up to 2026-06-30.
Figures computed from the financial statements: revenue 237.3 m USD in 2025; YoY growth 26.9%; net margin 13.0%; ROE 37.8%.
The estimated value range is 28.12–36.48 USD per share (median of 1 methods, agreement: single method); assumptions are illustrative. Against the central value of 35.99 USD, the price of 22.16 USD leaves a potential of 62.4% (value / price − 1) and a margin of safety of 38.4% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.
Insufficient data for a verdict (score weight coverage: 45.8% of at least 60%).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- ROIC: 23.2%
- Net margin: 13.0%
- Revenue CAGR 3Y: 20.4%
- Interest coverage: 6.9x
- Current ratio: 1.8x
- The price is below the estimated value range
What contradicts it
No signal among the computed factors. That is not an absence of risk: factors without data were not assessed, and business risks (margins, inventory, demand) are in the source-based analysis.
Not assessed (insufficient data or a ratio without meaning): FCF conversion, EPS CAGR 3Y, Net debt / EBITDA, EV/EBITDA, FCF yield, Shareholder yield (distributions), Payout ratio (FCF).
Versus the vertical median
Miscellaneous Chemical Products (SIC 2890) · same industry (4-digit SIC) · compared with 7 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| ESIElement Solutions Inc | 7.5 bn | 36.4 | 7.4% | 5.9% | +3.8% | +19% / +47% |
| CBTCabot Corp | 3.8 bn | 20.5 | 12.1% | 5.2% | −7.0% | +17% / −4% |
| WDFCWd-40 Company | 3.0 bn | 37.4 | 30.4% | 12.0% | +11.0% | +16% / −6% |
| FTKFlotek Industries Inc | 802.6 m | 22.4 | 37.8% | 13.0% | +26.9% | +31% / +405% |
| ASPIASP Isotopes Inc. | 263.7 m | — | -80.9% | -380.3% | +475.5% | −72% / −10% |
| OECOrion S.A. | 235.7 m | — | -8.1% | -1.8% | −3.8% | −18% / −83% |
| ARQArq, Inc. | 106.1 m | — | -25.0% | -38.5% | +10.4% | −35% / −11% |
| FSIFlexible Solutions International, Inc | 78.4 m | — | -8.2% | -8.8% | +0.7% | −10% / +304% |
1- and 3-year price returns: for FTK from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 15.36 Total return -31% · Per year -31% | 27.03 Total return 22% · Per year 22% | 40.55 Total return 83% · Per year 83% |
| 3 years | 18.22 Total return -18% · Per year -6% | 35.75 Total return 61% · Per year 17% | 58.39 Total return 164% · Per year 38% |
| 5 years | 21.61 Total return -2% · Per year -0% | 47.28 Total return 113% · Per year 16% | 84.09 Total return 279% · Per year 31% |
- Exit P/E± 8.94
- Net margin± 6.26
- Annual revenue growth± 4.67
- Annual dilution± 0.53
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 06 Aug 2026; since then the company filed 8-K (03 Nov 2026 · results).
In brief
Flotek Industries is a chemistry and data analytics company serving mainly the energy industry, with Chemistry Technologies and Data Analytics segments. Its second quarter of 2026 showed strong growth, and the Data Analytics segment became the largest contributor to gross profit, which draws attention to diversification beyond oil and gas 3.
SWOT
Strengths
- The company holds a rich technology portfolio, with granted patents and field data accumulated over two decades, which supports product differentiation 13.
- The Data Analytics segment has grown quickly and became the largest contributor to gross profit, showing the scalability of its model 3.
- International presence, especially in the Middle East, adds a revenue source outside the US market 3.
Weaknesses
- A large share of revenue depends on contracts with ProFrac affiliates, creating significant customer concentration risk 1.
- The company has large receivables from ProFrac entities, which can affect liquidity 1.
- The utility support contract was paused due to infrastructure delays, showing execution risk in new projects 2.
Opportunities
- The PREPA contract could extend the company into utility power, a market broader than oil and gas 2.
- If demand for energy outside the oil industry grows, the analytics segment could become a more diversified growth driver 3.
- Growing international chemistry activity could generate new contracts and revenue 3.
Risks
- Dependence on ProFrachigh
Revenue and liquidity depend heavily on contracts with ProFrac affiliates, and their financial problems could affect the company 1.
- Receivables collectionhigh
Amounts due from ProFrac entities, including minimum purchase shortfall fees, could be delayed or not paid in full 1.
- Execution of power contractsmedium
Infrastructure delays have paused power generation under the utility contract, which could also affect the Puerto Rico project 2.
- Industry cyclicalitymedium
Activity in the oil and gas industry is volatile, and downturns could quickly reduce demand for the company's products 1.
- Regulation and environmentmedium
Legislative changes on hydraulic fracturing and environmental requirements could raise costs or reduce demand 1.
Investment thesis
What would need to be true (bull case)
- Rapid growth in the Data Analytics segment and the raised guidance suggest the business model could keep growing if new projects are executed as planned 3.
- Utility and Puerto Rico power contracts could open a market broader than the oil industry and reduce dependence on a single customer 2.
- The patent portfolio and field experience could support technological differentiation and better margins over the long term 1.
What would break the thesis
- Revenue concentration on ProFrac and large receivables could create liquidity problems if the customer does not meet its obligations 1.
- The temporary pause of the utility contract shows that new projects could face delays that affect results 2.
- Oil and gas price cyclicality could quickly reduce demand and affect the company's recent growth 1.
What to watch
- Execution of the PREPA contract and start of equipment deliveriesQ4 2026 / Q1 2027
- Resumption of power generation under the utility contract and any extensionQ3 2026
- Trend in ProFrac-related revenue and collection of receivablesnext 10-Q
- Achievement of the raised 2026 guidanceQ4 2026
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 06 Aug 2026; since then the company filed 8-K (03 Nov 2026 · results).
The business
Flotek describes itself as a technology-driven chemistry and data analytics company that seeks to reduce the environmental impact of energy on air, water, land and people 1. It operates through two segments, Chemistry Technologies and Data Analytics, both supported by its Research and Innovation laboratory 1. Customers include energy companies, among them related party ProFrac, as well as industrial and alternative energy companies 1.
In the first half of 2026, the company raised its guidance for the year to total revenues of 340 to 350 million dollars, citing strong results and its outlook for the rest of the year 3. The power services contract with a Puerto Rico utility could substantially change the company's profile if executed as planned 2.
Segments
Chemistry Technologies
The CT segment designs, manufactures and distributes optimized chemistry solutions meant to improve return on invested capital and reduce operating costs for hydrocarbon producers 1. In the second quarter of 2026, segment revenue was 80.2 million dollars, the highest since 2017, and international revenue grew sharply, particularly in the Middle East 3.
Data Analytics
The DA segment provides near real-time measurement analytics through in-line optical spectrometers, along with equipment rentals and sales 1. In the second quarter of 2026 it reached a record 19.2 million dollars in revenue, and its gross profit contribution exceeded that of the chemistry segment 3. The utility support contract and Puerto Rico power project extend the segment into energy infrastructure 2.
Market context
Demand for Flotek's energy products depends on oil and gas drilling and completion activity in the US and internationally, as well as global energy demand 1. The company also identifies a growing market for real-time measurement solutions, driven by rising electricity demand and the need to reduce emissions 1. The market for real-time analytics and measurement could become more important if energy projects outside the oil sector keep growing 3.
Oil and natural gas prices, regulation of hydraulic fracturing and environmental requirements directly influence customer activity, and lower exploration spending could reduce sales 1. Diversification toward power and utility infrastructure opens a different market with its own demand and cycles 2.
Trends
- Electricity demand growthtailwind
Rising US electricity demand and the need for generation close to consumers could support the company's new power contracts 1.
- Oil and gas cyclicalityheadwind
Volatility in oil and natural gas prices can reduce customer activity and demand for the company's chemistry and analytics products 1.
- Environmental regulationmixed
Environmental rules and pressure for cleaner solutions can create demand for the company's technologies, but they can also raise compliance costs 1.
- Trade tariffsheadwind
Trade policies and tariffs on imported materials can raise raw material costs and affect margins if they cannot be passed on to customers 1.
Competitive position
In data analytics, Flotek competes with other providers of equipment and services for real-time information across upstream, midstream, refining and distribution 1. In chemistry, competition comes from traditional competitors and from wholesalers selling directly to customers 1.
The company's ability to differentiate through quality, service and a competitive cost structure is central, and competitive pressure could push prices down 1. Its agreements with ProFrac and its intellectual property portfolio of over 130 patents are its main differentiators 3.
- Traditional oilfield chemistry suppliers
Companies supplying chemicals for drilling and completion operations that compete directly with the CT segment 1.
- Chemical distributors selling directly to customers
Sellers that compete with Flotek by delivering products directly to industry operators 1.
- Providers of real-time measurement equipment
Firms offering real-time information across upstream, midstream and refining, competing with the DA segment 1.
- Mobile power generation providers
Companies offering power generation close to consumers, in the same niche as the company's new contracts 2.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
No news in our archive over the last 180 days.
SEC filings
- Current report03 Nov 2026Results of operations · Regulation FD disclosure · Financial statements and exhibits
- Current report23 Sept 2026Material agreement · Termination of a material agreement · Creation of a direct financial obligation · Regulation FD disclosure · Financial statements and exhibits
- Current report09 Sept 2026Regulation FD disclosure · Financial statements and exhibits
- Current report19 Aug 2026Other events · Financial statements and exhibits
- Current report18 Aug 2026Regulation FD disclosure · Other events · Financial statements and exhibits
- Quarterly report06 Aug 2026
- Current report04 Aug 2026Results of operations · Regulation FD disclosure · Financial statements and exhibits
- Current report03 Aug 2026Regulation FD disclosure · Financial statements and exhibits
- Current report17 Jul 2026Material agreement · Creation of a direct financial obligation · Financial statements and exhibits
- Current report15 May 2026Shareholder vote
Sources
- [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / Flotek Industries, Inc. · 16 Mar 2026
- [2] Form 10-Q, quarter ended 2026-06-30 · SEC / Flotek Industries, Inc. · 06 Aug 2026
- [3] Form 8-K, results release (exhibit 99.1) · SEC / Flotek Industries, Inc. · 04 Aug 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.